Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the USA / NCT07915700
Recruiting Not applicable

Hand Prosthesis Usability and Performance

NCT07915700 · tracked via the Priya Life Science USA tracker
Sponsor
Össur Iceland ehf
Phase
Not applicable
Started
2026-03-09
Last updated
2026-11-04

Condition(s) studied

Amputation

Investigational drug(s) / intervention(s)

Prototype hand prosthesisBaseline Comparator Device

Prototype hand prosthesis: Prototype hand prosthesis

Baseline Comparator Device: All participants will use their own prosthesis

Study summary

This study asks individuals with upper limb absence to use a new hand prosthesis, and compare it's performance to their own hand prosthesis

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Multi-articulating hand experience * At least 18 years old * Transradial, acquired amputation or congenital upper limb absence * Unilateral upper limb absence preferred Good socket comfort in own prosthesis (\>/= 6 on Hanspal socket comfort score) Exclusion Criteria: * Any health conditions that pose a risk to participation in study events (in the opinion of the Investigator), e.g. Visual impairment; Cognitive impairment * Cognitively unable to provide informed consent or comply with the study procedures

Primary outcome measure(s)

  • Grip Accuracy — At baseline and each post-treatment visit (x3 visits over 12 weeks)
    Functional observer rated test of ability to perform grips. This test assesses the feasibility that the device can be used as a reliable hand prosthesis when operated by the intended use population. An observer rates the successful achievement of the prompted outcome on a 0-3 scale (0= no output, 3= output achieved without error). The four grips (hand open, hand close, thumb rotation to palm, thumb rotation away from palm) are repeated x3, resulting in a minimum summary score of 0 or a maximum summary score of 36.

Trial sites (1)

FacilityCityRegionStatus
Ossur Americas Dublin Ohio Recruiting

More Össur Iceland ehf trials in the USA

Pro APP Prosthetic Outcome Registry Recruiting

Other trials for the same condition

Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees Recruiting
Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses Recruiting
Detecting Change in Muscle Parameters, Pain, and Function With NMES for TTA Recruiting
Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss Recruiting
Effects of Microprocessor-controlled Prosthetic Knees on Fall-related Health Outcomes in Limited Community Ambulators Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07915700 on ClinicalTrials.gov ↗ ← All trials in the USA